Ignite Creation Date:
2024-05-06 @ 12:09 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01506609
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2012-01-06
Brief Title:
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide TMZ or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene BRCA1 and BRCA2 Mutation and Metastatic Breast Cancer
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
M12-895
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None